Compared with those in non-VAP patients, the median levels of IL-6 in mcVAP and suspVAP patients were significantly elevated starting the day before diagnosis (Figure 3). Additionally, we detected significant differences in PCT and CRP levels on days one, two, and three (Figures 3-7, Suppl. This evidence concerns the gene CRP and ventilator-associated pneumonia.